SUNLENCA 464 MG SOLUCION INYECTABLE

Gilead Sciences Ireland Unlimited Company🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e748b9106ebac751
Drug Cima Aemps Name: SUNLENCA 464 MG SOLUCION INYECTABLE
Register Number: 1221671002
Holder Company Name: Gilead Sciences Ireland Unlimited Company
Marketing Company Name: Gilead Sciences S.L.
Holder Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company
Authorization Date: 2022-09-16
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 464 MG
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Gilead Sciences Ireland Unlimited Company
Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company

LENACAPAVIR SODIO

315,4 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 16, 2022

Approval ID

e748b9106ebac751

Type

Standard